Several studies reported that the expression and regulatory roles of CP2c and YY1 might affect the development of cancer individually; however, the association between the interaction of these proteins and the prognosis of patients with breast cancer has not yet been investigated. The gene discussed is YY1; the disease is breast carcinoma.